this stock is primed to go pretty low. no buying. no hype. literally, it is dead. if they were confident the FDA approval was coming we'd see at least some buying going on.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.